NCT04407741 2023-12-12
Phase â… /â…¡ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas
Chinese PLA General Hospital
Phase 1/2 Unknown
Clinical Trials
14 trialsNCT05106023 2023-06-07
To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
Fudan University
Phase 2 Unknown
NCT04580498 2023-05-19
A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT03774979 2022-11-08
SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT04355858 2022-07-26
MULAN
Fudan University
Phase 2 Unknown
NCT05198817 2022-06-28
A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT04679038 2022-01-26
A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Unknown
NCT05177497 2022-01-04
SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC
Shanghai Chest Hospital
Phase 2 Unknown
NCT04282070 2021-12-21
SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT05132413 2021-11-24
A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Unknown
NCT03710265 2021-11-22
SHR-1701 in Metastatic or Locally Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT04650633 2021-10-29
SHR-1701 in Patients With Recurrent/Metastatic Scchn
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT04884009 2021-05-12
A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT04560244 2020-09-23
A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment
Shandong Cancer Hospital and Institute
Phase 2 Unknown